H 97 (Lithium 150 mg)

Pill imprint H 97 has been identified as Lithium carbonate 150 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for H 97

Lithium carbonate 150 mg H 97
Lithium carbonate
Imprint:
H
97
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Hetero Drugs Limited
National Drug Code (NDC):
65977-5044
Inactive Ingredients:
magnesium silicate
gelatin
titanium dioxide
sodium lauryl sulfate
FD&C Red No. 40
shellac
alcohol
isopropyl alcohol
butyl alcohol
propylene glycol
ammonia
ferrosoferric oxide
potassium hydroxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)